$PFE Recent News Pfizer a buy after merger tal
Post# of 72709
Posted On: 06/06/2014 10:13:16 AM
$PFE Recent News
Pfizer a buy after merger talks break down: Goldman 11:12 a.m. May 28, 2014 - Ben Eisen
Stay tuned for more drama in Pfizer-AstraZeneca saga, analysts say 3:15 p.m. May 27, 2014 - blogs.marketwatch.com
U.K. stocks up as InterContinental jumps amid bid talk 12:52 p.m. May 27, 2014 - Carla Mozee
European stocks gain, but AstraZeneca slumps 12:18 p.m. May 27, 2014 - Carla Mozee
Is the fate of the stock market in the IRS’s hands? 11:33 a.m. May 27, 2014 - Simon Constable
Newscast: Wall Street continues to gain ground 9:58 a.m. May 27, 2014 - MarketWatch
Newscast: Pfizer walks away from AstraZeneca 7:31 a.m. May 27, 2014 - MarketWatch
Pfizer walks away from AstraZeneca deal 4:02 a.m. May 27, 2014 - Geoffrey Rogow
AstraZeneca boosts FTSE 100 after two days in red 12:28 p.m. May 21, 2014 - Sara Sjolin
AstraZeneca shares creep back up amid urges to reconsider Pfizer deal 12:15 p.m. May 21, 2014 - blogs.marketwatch.com
5 value stocks for investors who fear the worst 10:14 a.m. May 21, 2014 - Philip van Doorn
The best thing about Pfizer’s failure with AstraZeneca 4:00 a.m. May 21, 2014 - Matthew Lynn
U.S. stocks gain as Apple, Russell 2000 rise 1% 5:03 p.m. May 19, 2014 - Anora Mahmudova
Newscast: Stocks open week with a win 4:33 p.m. May 19, 2014 - MarketWatch
Apple reclaims $600 mark; AT&T down on DirecTV deal 3:37 p.m. May 19, 2014 - Saumya Vaishampayan
Stocks rise for second day; small-caps, tech lead: Stock market live blog recap 3:31 p.m. May 19, 2014 - blogs.marketwatch.com
Who can afford AstraZeneca's asking price? Not many, analysts say 2:18 p.m. May 19, 2014 - blogs.marketwatch.com
Investors welcome Pfizer's latest rejection 12:34 p.m. May 19, 2014 - MarketWatch
FTSE 100 yanked lower by AstraZeneca, miners 12:31 p.m. May 19, 2014 - Sara Sjolin
AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer 12:20 p.m. May 19, 2014 - Sara Sjolin
Genomic Health Up on Fresh Cancer Study Data - Analyst Blog 2:50 p.m. June 5, 2014 - Zacks.com
4 Cheap Off the Radar Small-Cap Stocks 8:29 a.m. June 5, 2014 - Barrons.com
Lannett Tops Trio Of Medical Small Cap Leaders 7:02 a.m. June 5, 2014 - Investors Business Daily
Top 10 Net Payout Yield Stocks For June 2014 5:13 a.m. June 5, 2014 - Seeking Alpha
Positive ASCO Updates from Novartis - Analyst Blog 5:50 p.m. June 4, 2014 - Zacks.com
What's in Phil Mickelson's Portfolio? Clorox, Barclays and 3 More He Endorses 2:06 p.m. June 4, 2014 - TheStreet.com
Jana Partners' Favorite Stocks 11:58 a.m. June 4, 2014 - Barrons.com
Watch Out For The Buyback Taper 11:26 a.m. June 4, 2014 - Seeking Alpha
OTC Cialis? Pfizer’s Viagra Will Be Just Fine 9:28 a.m. June 4, 2014 - InvestorPlace.com
M&A Activity Fearless Against Rate Hikes 8:49 a.m. June 4, 2014 - FOXBusiness
Pfizer and KineMed extend collaboration 7:40 a.m. June 4, 2014 - Seeking Alpha
Retirement Strategy: My "Buy The Dips Portfolio": When To Add, When To Sell, And My Ultimate Format 7:30 a.m. June 3, 2014 - Seeking Alpha
Wall Street Breakfast: Must-Know News 6:31 a.m. June 3, 2014 - Seeking Alpha
PFE: Pfizer to Pay $325M Fine for Illegal Marketing 4:29 a.m. June 3, 2014 - InvestorPlace.com
AstraZeneca Upbeat on Drug Pipeline 3:32 a.m. June 3, 2014 - The Wall Street Journal Interactive Edition
Pfizer to pay $325M fine to third party payers 8:39 p.m. June 2, 2014 - Seeking Alpha
Humana Files RICO Claim Over Medtronic Bone Drug 7:58 p.m. June 2, 2014 - The Wall Street Journal Interactive Edition
Can Pfizer Break Higher? 4:04 p.m. June 2, 2014 - Wall St. Cheat Sheet
Does GlaxoSmithKline Have a Bright Future? 4:01 p.m. June 2, 2014 - Wall St. Cheat Sheet
Pfizer (PFE) Showing Signs Of Being Water-Logged And Getting Wetter 3:33 p.m. June 2, 2014 - TheStreet.com
Study Results, Updated Organization Structures, Appointments, and Technical Updates - Analyst Notes on Johnson & Johnson, Pfizer, Teva, Express Scripts and Idenix Pharmaceuticals 6:10 a.m. June 5, 2014 - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 10:00 a.m. June 4, 2014 - BusinessWire - BZX
KineMed Collaboration with Pfizer Inc. in Diabetes is Extended 6:00 a.m. June 4, 2014 - BusinessWire - BZX
Data Review on Active Stocks -- Research on SIRIUS XM, Twitter, Pfizer, and Vale 8:30 a.m. June 3, 2014 - PR Newswire - PRF
Mylan Settles Patent Litigation Related to Celebrex® Capsules 7:00 a.m. June 2, 2014 - PR Newswire - PRF
Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research 11:14 a.m. May 29, 2014 - BusinessWire - BZX
Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development 8:30 a.m. May 29, 2014 - BusinessWire - BZX
ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R) 4:06 p.m. May 27, 2014 - GlobeNewswire
Must Watch News: Pfizer Inc, AT&T, Alpha Natural Resources, Sprint Corporation 9:06 a.m. May 27, 2014 - ACCESSWIRE
Pfizer BringsFrequent Heartburn ReliefOver-the-Counter with New Nexium® 24HR 8:31 a.m. May 27, 2014 - BusinessWire - BZX
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Statement from Pfizer Inc. 10:05 a.m. May 26, 2014 - BusinessWire - BZX
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis 9:13 a.m. May 23, 2014 - BusinessWire - BZX
BioRestorative Therapies Signs Research Agreement with Pfizer Inc. 8:01 a.m. May 22, 2014 - BusinessWire - BZX
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 11:59 a.m. May 21, 2014 - PR Newswire - PRF
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 11:40 a.m. May 21, 2014 - PR Newswire - PRF
New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace 8:15 a.m. May 21, 2014 - BusinessWire - BZX
GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial 4:01 p.m. May 20, 2014 - BusinessWire - BZX
Statement from Pfizer Inc. 6:41 p.m. May 19, 2014 - BusinessWire - BZX
Senesco Completes Acquisition of Fabrus 8:31 a.m. May 19, 2014 - BusinessWire - BZX
Pfizer a buy after merger talks break down: Goldman 11:12 a.m. May 28, 2014 - Ben Eisen
Stay tuned for more drama in Pfizer-AstraZeneca saga, analysts say 3:15 p.m. May 27, 2014 - blogs.marketwatch.com
U.K. stocks up as InterContinental jumps amid bid talk 12:52 p.m. May 27, 2014 - Carla Mozee
European stocks gain, but AstraZeneca slumps 12:18 p.m. May 27, 2014 - Carla Mozee
Is the fate of the stock market in the IRS’s hands? 11:33 a.m. May 27, 2014 - Simon Constable
Newscast: Wall Street continues to gain ground 9:58 a.m. May 27, 2014 - MarketWatch
Newscast: Pfizer walks away from AstraZeneca 7:31 a.m. May 27, 2014 - MarketWatch
Pfizer walks away from AstraZeneca deal 4:02 a.m. May 27, 2014 - Geoffrey Rogow
AstraZeneca boosts FTSE 100 after two days in red 12:28 p.m. May 21, 2014 - Sara Sjolin
AstraZeneca shares creep back up amid urges to reconsider Pfizer deal 12:15 p.m. May 21, 2014 - blogs.marketwatch.com
5 value stocks for investors who fear the worst 10:14 a.m. May 21, 2014 - Philip van Doorn
The best thing about Pfizer’s failure with AstraZeneca 4:00 a.m. May 21, 2014 - Matthew Lynn
U.S. stocks gain as Apple, Russell 2000 rise 1% 5:03 p.m. May 19, 2014 - Anora Mahmudova
Newscast: Stocks open week with a win 4:33 p.m. May 19, 2014 - MarketWatch
Apple reclaims $600 mark; AT&T down on DirecTV deal 3:37 p.m. May 19, 2014 - Saumya Vaishampayan
Stocks rise for second day; small-caps, tech lead: Stock market live blog recap 3:31 p.m. May 19, 2014 - blogs.marketwatch.com
Who can afford AstraZeneca's asking price? Not many, analysts say 2:18 p.m. May 19, 2014 - blogs.marketwatch.com
Investors welcome Pfizer's latest rejection 12:34 p.m. May 19, 2014 - MarketWatch
FTSE 100 yanked lower by AstraZeneca, miners 12:31 p.m. May 19, 2014 - Sara Sjolin
AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer 12:20 p.m. May 19, 2014 - Sara Sjolin
Genomic Health Up on Fresh Cancer Study Data - Analyst Blog 2:50 p.m. June 5, 2014 - Zacks.com
4 Cheap Off the Radar Small-Cap Stocks 8:29 a.m. June 5, 2014 - Barrons.com
Lannett Tops Trio Of Medical Small Cap Leaders 7:02 a.m. June 5, 2014 - Investors Business Daily
Top 10 Net Payout Yield Stocks For June 2014 5:13 a.m. June 5, 2014 - Seeking Alpha
Positive ASCO Updates from Novartis - Analyst Blog 5:50 p.m. June 4, 2014 - Zacks.com
What's in Phil Mickelson's Portfolio? Clorox, Barclays and 3 More He Endorses 2:06 p.m. June 4, 2014 - TheStreet.com
Jana Partners' Favorite Stocks 11:58 a.m. June 4, 2014 - Barrons.com
Watch Out For The Buyback Taper 11:26 a.m. June 4, 2014 - Seeking Alpha
OTC Cialis? Pfizer’s Viagra Will Be Just Fine 9:28 a.m. June 4, 2014 - InvestorPlace.com
M&A Activity Fearless Against Rate Hikes 8:49 a.m. June 4, 2014 - FOXBusiness
Pfizer and KineMed extend collaboration 7:40 a.m. June 4, 2014 - Seeking Alpha
Retirement Strategy: My "Buy The Dips Portfolio": When To Add, When To Sell, And My Ultimate Format 7:30 a.m. June 3, 2014 - Seeking Alpha
Wall Street Breakfast: Must-Know News 6:31 a.m. June 3, 2014 - Seeking Alpha
PFE: Pfizer to Pay $325M Fine for Illegal Marketing 4:29 a.m. June 3, 2014 - InvestorPlace.com
AstraZeneca Upbeat on Drug Pipeline 3:32 a.m. June 3, 2014 - The Wall Street Journal Interactive Edition
Pfizer to pay $325M fine to third party payers 8:39 p.m. June 2, 2014 - Seeking Alpha
Humana Files RICO Claim Over Medtronic Bone Drug 7:58 p.m. June 2, 2014 - The Wall Street Journal Interactive Edition
Can Pfizer Break Higher? 4:04 p.m. June 2, 2014 - Wall St. Cheat Sheet
Does GlaxoSmithKline Have a Bright Future? 4:01 p.m. June 2, 2014 - Wall St. Cheat Sheet
Pfizer (PFE) Showing Signs Of Being Water-Logged And Getting Wetter 3:33 p.m. June 2, 2014 - TheStreet.com
Study Results, Updated Organization Structures, Appointments, and Technical Updates - Analyst Notes on Johnson & Johnson, Pfizer, Teva, Express Scripts and Idenix Pharmaceuticals 6:10 a.m. June 5, 2014 - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 10:00 a.m. June 4, 2014 - BusinessWire - BZX
KineMed Collaboration with Pfizer Inc. in Diabetes is Extended 6:00 a.m. June 4, 2014 - BusinessWire - BZX
Data Review on Active Stocks -- Research on SIRIUS XM, Twitter, Pfizer, and Vale 8:30 a.m. June 3, 2014 - PR Newswire - PRF
Mylan Settles Patent Litigation Related to Celebrex® Capsules 7:00 a.m. June 2, 2014 - PR Newswire - PRF
Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research 11:14 a.m. May 29, 2014 - BusinessWire - BZX
Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development 8:30 a.m. May 29, 2014 - BusinessWire - BZX
ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R) 4:06 p.m. May 27, 2014 - GlobeNewswire
Must Watch News: Pfizer Inc, AT&T, Alpha Natural Resources, Sprint Corporation 9:06 a.m. May 27, 2014 - ACCESSWIRE
Pfizer BringsFrequent Heartburn ReliefOver-the-Counter with New Nexium® 24HR 8:31 a.m. May 27, 2014 - BusinessWire - BZX
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Statement from Pfizer Inc. 10:05 a.m. May 26, 2014 - BusinessWire - BZX
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis 9:13 a.m. May 23, 2014 - BusinessWire - BZX
BioRestorative Therapies Signs Research Agreement with Pfizer Inc. 8:01 a.m. May 22, 2014 - BusinessWire - BZX
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 11:59 a.m. May 21, 2014 - PR Newswire - PRF
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 11:40 a.m. May 21, 2014 - PR Newswire - PRF
New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace 8:15 a.m. May 21, 2014 - BusinessWire - BZX
GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial 4:01 p.m. May 20, 2014 - BusinessWire - BZX
Statement from Pfizer Inc. 6:41 p.m. May 19, 2014 - BusinessWire - BZX
Senesco Completes Acquisition of Fabrus 8:31 a.m. May 19, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼